Filing Details

Accession Number:
0001358403-16-000207
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-06 16:06:12
Reporting Period:
2016-06-02
Filing Date:
2016-06-06
Accepted Time:
2016-06-06 16:06:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1358403 Bellicum Pharmaceuticals Inc BLCM Pharmaceutical Preparations (2834) 201450200
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1626895 Ken Moseley C/O Bellicum Pharmaceuticals, Inc.
2130 W. Holcombe Blvd., Ste. 800
Houston TX 77030
Sr. Vp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-02 15,000 $2.55 15,196 No 4 M Direct
Common Stock Disposition 2016-06-02 15,000 $13.00 196 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-06-02 15,000 $0.00 15,000 $2.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,823 2022-12-31 No 4 M Direct
Footnotes
  1. Includes 99 shares acquired under the Issuer's Employee Stock Purchase Plan on December 10, 2015.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
  3. 25% of the shares subject to the stock option vested and became exercisable on January 1, 2014, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.